Table 1.
Baseline Characteristics of High-risk Sample
| Gender | |
| Males | 26(65%) |
| Females | 14(35%) |
| Total | 40 |
| Age (yrs.) | 16.67(3.29) |
| Parental Education | 14.55(3.06) |
| FSIQ a | 103.73(14.39) |
| Medication | |
| Stimulants | 02(5%) |
| Antidepressants | 21(52.5%) |
| Antipsychotics | 11(27.5%) |
| Movement Abnormalities b | 6.88(3.34) |
| Psychosocial Function c | |
| GFS-S | 5.73(1.69) |
| GFS-R | 5.30(1.82) |
| Prodromal Symptoms d | |
| Positive | 2.57(.83) |
| Negative | 2.23(1.15) |
Note: In the present study, 30 participants were taking one or more medications at baseline, and 10 were medication free.
a
Full Scale IQ (FSIQ) estimate is a derived index based on 2-subtest Wechsler Abbreviated Scale for Intelligence (WASI; Vocabulary and Matrix Reasoning subtests).
b
Movement symptoms reflect mean scores from the Dyskinesia Identification System (DISCUS)
c
Psychosocial functioning scores derived from GSF/GRF scales
d
Means and standard deviations for SIPS symptom scores at baseline.